Iterative Scopes brings gastrointestinal disease AI to Janssen's IBD clinical trials

After chipping in to its last two venture funding rounds, Johnson & Johnson is taking an even bigger chance on Iterative Scopes.

Related Keywords

Massachusetts ,United States ,Theravance Biopharma ,Johnson ,Iterative Scopes ,Iterative Scope ,Janssen ,Ohnson Amp Johnson ,Crohn 039s Disease ,Ulcerative Colitis ,Clinical Trial ,Artificial Intelligence ,Inflammatory Bowel Disease ,Partnerships ,Startups ,Medtech ,